Skip to main content

Table 3 Albumin quotient (QAlb) distribution in the study population by sex, age and specific disease status

From: Increased age and male sex are independently associated with higher frequency of blood–cerebrospinal fluid barrier dysfunction using the albumin quotient

 

Females

Males

p

ALL, n (%)

718 (59.4)

491 (40.6)

 

QAlb: median (IQR)

4.87 (3.69–6.88)

7.18 (4.91–11.30)

< 0.0001

 Age 16–40 years: median (IQR)

4.19 (3.28–5.41)

5.74 (4.40–9.20)

< 0.0001

 Age 41–60 years: median (IQR)

5.03 (3.88–7.83)

7.33 (4.87–11.26)

< 0.0001

 Age > 60 years: median (IQR)

6.52 (4.93–10.96)

8.87 (5.82–15.43)

0.0008

MS, n (%)

204 (68.7)

93 (31.3)

 

 QAlb: median (IQR)

4.10 (3.27–5.36)

5.22 (4.15–7.61)

< 0.0001

OIND, n (%)

132 (47.0)

149 (53.0)

 

 QAlb: median (IQR)

6.68 (4.54–13.1)

9.22 (5.65–15.00)

0.0172

NIND, n (%)

146 (49.2)

151 (50.8)

 

 QAlb: median (IQR)

5.09 (3.87–6.58)

6.34 (4.64–9.42)

< 0.0001

UNK, n (%)

236 (70.7)

98 (29.3)

 

 QAlb: median (IQR)

4.89 (3.70–7.38)

8.48 (6.2–12.4)

< 0.0001

  1. Mann–Whitney u-test was used for all comparisons
  2. ALL patient groups analysed as a whole, MS multiple sclerosis, NIND non-inflammatory neurological diseases, OIND other inflammatory neurological diseases, UNK unknown-neurological diagnosis